Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-27462149

RESUMO

INTRODUCTION: Severe chronic obstructive pulmonary disease (COPD) is often associated with secondary pulmonary hypertension (PH), which worsens prognosis. PH can be lowered by oxygen, but also by inhaled nitric oxide (NO), which has the potential to improve the health status of these patients. NO is an important mediator in vascular reactions in the pulmonary circulation. Oral compounds can act through NO-mediated pathways, but delivering pulsed inhaled NO (iNO) directly to the airways and pulmonary vasculature could equally benefit patients. Therefore, a proof-of-concept study was performed to quantify pulmonary blood vessel caliber changes after iNO administration using computed tomography (CT)-based functional respiratory imaging (FRI). METHODS: Six patients with secondary PH due to COPD received "pulsed" iNO in combination with oxygen for 20 minutes via a nasal cannula. Patients underwent a high-resolution CT scan with contrast before and after iNO. Using FRI, changes in volumes of blood vessels and associated lobes were quantified. Oxygen saturation and blood pressure were monitored and patients were asked about their subjective feelings. RESULTS: Pulmonary blood vessel volume increased by 7.06%±5.37% after iNO. A strong correlation (Ω(2) 0=0.32, P=0.002) was obtained between ventilation and observed vasodilation, suggesting that using the pulsed system, iNO is directed toward the ventilated zones, which consequently experience more vasodilation. Patients did not develop oxygen desaturation, remained normotensive, and perceived an improvement in their dyspnea sensation. CONCLUSION: Inhalation of pulsed NO with oxygen causes vasodilation in the pulmonary circulation of COPD patients, mainly in the well-ventilated areas. A high degree of heterogeneity was found in the level of vasodilation. Patients tend to feel better after the treatment. Chronic use trials are warranted.


Assuntos
Anti-Hipertensivos/administração & dosagem , Hipertensão Pulmonar/tratamento farmacológico , Pulmão/irrigação sanguínea , Óxido Nítrico/administração & dosagem , Oxigenoterapia , Artéria Pulmonar/efeitos dos fármacos , Doença Pulmonar Obstrutiva Crônica/terapia , Vasodilatação/efeitos dos fármacos , Vasodilatadores/administração & dosagem , Administração por Inalação , Idoso , Anti-Hipertensivos/efeitos adversos , Pressão Arterial/efeitos dos fármacos , Angiografia por Tomografia Computadorizada , Feminino , Volume Expiratório Forçado , Humanos , Hipertensão Pulmonar/diagnóstico , Hipertensão Pulmonar/etiologia , Hipertensão Pulmonar/fisiopatologia , Pulmão/fisiopatologia , Masculino , Óxido Nítrico/efeitos adversos , Oxigenoterapia/efeitos adversos , Satisfação do Paciente , Imagem de Perfusão , Artéria Pulmonar/diagnóstico por imagem , Artéria Pulmonar/fisiopatologia , Circulação Pulmonar/efeitos dos fármacos , Doença Pulmonar Obstrutiva Crônica/complicações , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Pulsoterapia , Fatores de Tempo , Resultado do Tratamento , Vasodilatadores/efeitos adversos , Capacidade Vital
2.
Artigo em Inglês | MEDLINE | ID: mdl-26917956

RESUMO

BACKGROUND: Patients with COPD show a significant reduction of the lobar hyperinflation at the functional residual capacity level in the patients who improved >120 mL in forced expiratory volume in 1 second (FEV1) after 6 months of treatment with roflumilast in addition to inhaled corticosteroids (ICSs)/long-acting beta-2 agonists (LABAs)/long-acting muscarinic antagonists (LAMAs). METHODS: Functional respiratory imaging was used to quantify lobar hyperinflation, blood vessel density, ventilation, aerosol deposition, and bronchodilation. To investigate the exact mode of action of roflumilast, correlations between lobar and global measures have been tested using a mixed-model approach with nested random factors and Pearson correlation, respectively. RESULTS: The reduction in lobar hyperinflation appears to be associated with a larger blood vessel density in the respective lobes (t=-2.154, P=0.040); lobes with a higher percentage of blood vessels reduce more in hyperinflation in the responder group. Subsequently, it can be observed that lobes that reduce in hyperinflation after treatment are better ventilated (t=-5.368, P<0.001). Functional respiratory imaging (FRI)-based aerosol deposition showed that enhanced ventilation leads to more peripheral particle deposition of ICS/LABA/LAMA in the better-ventilated areas (t=2.407, P=0.024). Finally, the study showed that areas receiving more particles have increased FRI-based bronchodilation (t=2.564, P=0.017), leading to an increase in FEV1 (R=0.348, P=0.029). CONCLUSION: The study demonstrated that orally administered roflumilast supports the reduction of regional hyperinflation in areas previously undertreated by inhalation medication. The local reduction in hyperinflation induces a redistribution of ventilation and aerosol deposition, leading to enhanced efficacy of the concomitant ICS/LABA/LAMA therapy. FRI appears to be a sensitive tool to describe the mode of action of novel compounds in chronic obstructive pulmonary disease. Future studies need to confirm the enhanced sensitivity and the potential of FRI parameters to act as surrogates for clinically relevant, but more difficult to measure, end points such as exacerbations.


Assuntos
Corticosteroides/administração & dosagem , Aminopiridinas , Benzamidas , Antagonistas Muscarínicos/administração & dosagem , Doença Pulmonar Obstrutiva Crônica , Ventilação Pulmonar/efeitos dos fármacos , Testes de Função Respiratória/métodos , Administração por Inalação , Administração Oral , Agonistas de Receptores Adrenérgicos beta 2/administração & dosagem , Idoso , Aminopiridinas/administração & dosagem , Aminopiridinas/farmacocinética , Benzamidas/administração & dosagem , Benzamidas/farmacocinética , Broncodilatadores/administração & dosagem , Ciclopropanos/administração & dosagem , Ciclopropanos/farmacocinética , Quimioterapia Combinada/métodos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Inibidores da Fosfodiesterase 4/administração & dosagem , Inibidores da Fosfodiesterase 4/farmacocinética , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Índice de Gravidade de Doença , Distribuição Tecidual , Tomografia Computadorizada por Raios X/métodos , Resultado do Tratamento
3.
J Aerosol Med Pulm Drug Deliv ; 28(2): 88-99, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25004168

RESUMO

BACKGROUND: The efficacy of inhaled corticosteroids (ICS) in moderately severe COPD patients remains unclear. At the same time, the use of extrafine particles in COPD patients is a topic of ongoing research. OBJECTIVES: This study assessed the effect of ICS in steroid-naïve mild COPD patients and the effect of reducing the ICS dose in more severe COPD patients previously using ICS when switching to an extrafine particle BDP/F formulation (Foster using Modulite technology, Chiesi Pharmaceutici, Parma, Italy). METHODS: Novel functional respiratory imaging (FRI) methods, consisting of multi-slice CT scans and Computational Fluid Dynamics, were used in combination with conventional pulmonary function tests and patient reported outcomes. RESULTS: The study showed that the administration of extrafine BDP/F after 4-6 h led to a significant improvement in lung function parameters and hyperinflation as determined by spirometry, body plethysmography, and functional respiratory imaging. After 6 months of treatment, it was observed that, compared to baseline, the hyperinflation on lobar level at total lung capacity was significantly reduced (-1.19±7.19 %p, p=0.009). In addition, a significant improvement in SGRQ symptom score was noted in the entire patient population. Patients who improved in terms of hyperinflation also improved their MMRC dyspnea score. CFD indicated a difference in regional deposition between extrafine and non-extrafine formulations with -11% extrathoracic deposition and up to +4% lobe deposition for the extrafine formulation. CONCLUSIONS: The study showed that the administration of extrafine BDP/F improved lung function parameters and hyperinflation. Patients previously treated with ICS remained stable despite the lower dose, while ICS naïve patients improved in terms of lobar hyperinflation. FRI seems to be a sensitive biomarker to detect clinically relevant changes that are not detected by spirometry. The next step is to confirm these findings in a controlled trial.


Assuntos
Agonistas de Receptores Adrenérgicos beta 2/administração & dosagem , Beclometasona/administração & dosagem , Broncodilatadores/administração & dosagem , Dispneia/tratamento farmacológico , Fumarato de Formoterol/administração & dosagem , Glucocorticoides/administração & dosagem , Pulmão/efeitos dos fármacos , Tomografia Computadorizada Multidetectores , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Administração por Inalação , Agonistas de Receptores Adrenérgicos beta 2/química , Aerossóis , Idoso , Idoso de 80 Anos ou mais , Beclometasona/química , Broncodilatadores/química , Química Farmacêutica , Dispneia/diagnóstico , Dispneia/fisiopatologia , Feminino , Volume Expiratório Forçado , Fumarato de Formoterol/química , Glucocorticoides/química , Humanos , Pulmão/diagnóstico por imagem , Pulmão/fisiopatologia , Masculino , Pessoa de Meia-Idade , Tamanho da Partícula , Projetos Piloto , Pletismografia Total , Pós , Valor Preditivo dos Testes , Estudos Prospectivos , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Interpretação de Imagem Radiográfica Assistida por Computador , Recuperação de Função Fisiológica , Índice de Gravidade de Doença , Espirometria , Fatores de Tempo , Resultado do Tratamento , Capacidade Vital
5.
Artigo em Inglês | MEDLINE | ID: mdl-24293993

RESUMO

BACKGROUND: Previous studies have demonstrated the potential beneficial effect of N-acetylcysteine (NAC) in chronic obstructive pulmonary disease (COPD). However, the required dose and responder phenotype remain unclear. The current study investigated the effect of high-dose NAC on airway geometry, inflammation, and oxidative stress in COPD patients. Novel functional respiratory imaging methods combining multislice computed tomography images and computer-based flow simulations were used with high sensitivity for detecting changes induced by the therapy. METHODS: Twelve patients with Global Initiative for Chronic Obstructive Lung Disease stage II COPD were randomized to receive NAC 1800 mg or placebo daily for 3 months and were then crossed over to the alternative treatment for a further 3 months. RESULTS: Significant correlations were found between image-based resistance values and glutathione levels after treatment with NAC (P = 0.011) and glutathione peroxidase at baseline (P = 0.036). Image-based resistance values appeared to be a good predictor for glutathione peroxidase levels after NAC (P = 0.02), changes in glutathione peroxidase levels (P = 0.035), and reduction in lobar functional residual capacity levels (P = 0.00084). In the limited set of responders to NAC therapy, the changes in airway resistance were in the same order as changes induced by budesonide/formoterol. CONCLUSION: A combination of glutathione, glutathione peroxidase, and imaging parameters could potentially be used to phenotype COPD patients who would benefit from addition of NAC to their current therapy. The findings of this small pilot study need to be confirmed in a larger pivotal trial.


Assuntos
Acetilcisteína/uso terapêutico , Resistência das Vias Respiratórias/efeitos dos fármacos , Antioxidantes/uso terapêutico , Pulmão/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Idoso , Simulação por Computador , Estudos Cross-Over , Feminino , Volume Expiratório Forçado , Capacidade Residual Funcional , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Humanos , Pulmão/imunologia , Pulmão/metabolismo , Pulmão/fisiopatologia , Masculino , Pessoa de Meia-Idade , Modelos Biológicos , Tomografia Computadorizada Multidetectores , Fenótipo , Projetos Piloto , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Doença Pulmonar Obstrutiva Crônica/imunologia , Doença Pulmonar Obstrutiva Crônica/metabolismo , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Fatores de Tempo , Resultado do Tratamento
6.
Artigo em Inglês | MEDLINE | ID: mdl-23055715

RESUMO

OBJECTIVE: Chest physiotherapy enhances sputum evacuation in COPD patients. It can be applied as a single technique or as a combination of techniques including intrapulmonary percussive ventilation (IPV). Recently developed assessment techniques may provide new insights into the effect of airway clearance techniques. PARTICIPANTS: Five moderate to severe COPD patients (three females and two males; mean forced expiratory volume in 1 second of 39.49% predicted) who were admitted in the hospital for an acute exacerbation were included in this study. METHODS: A novel imaging technique was used, together with other conventional techniques, to visualize the short-term effects of a single IPV treatment in COPD patients. RESULTS: No significant changes were noted in the lung function parameters or arterial blood gases measured within 1 hour after the end of the IPV session. Computed tomography images detected changes in the airway patency after the IPV treatment compared with before treatment. Local resistances, calculated for the three-dimensional models, showed local changes in airway resistance. CONCLUSION: The effects of a single IPV session can be visualized by functional imaging. This functional imaging allows a calculation of changes in local airway resistance and local changes in airway volume in COPD patients without affecting conventional lung function parameters.


Assuntos
Simulação por Computador , Pulmão/diagnóstico por imagem , Modelos Biológicos , Doença Pulmonar Obstrutiva Crônica/diagnóstico por imagem , Doença Pulmonar Obstrutiva Crônica/terapia , Interpretação de Imagem Radiográfica Assistida por Computador/métodos , Respiração Artificial/métodos , Terapia Respiratória/métodos , Tomografia Computadorizada por Raios X , Resistência das Vias Respiratórias , Bélgica , Gasometria , Feminino , Volume Expiratório Forçado , Hospitalização , Humanos , Hidrodinâmica , Imageamento Tridimensional , Pulmão/fisiopatologia , Medidas de Volume Pulmonar , Masculino , Valor Preditivo dos Testes , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Índice de Gravidade de Doença , Fatores de Tempo , Resultado do Tratamento
7.
Eur J Ageing ; 8(4): 233-241, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28798653

RESUMO

Developed countries throughout the world are challenged with the ageing of their labour force. In these societal contexts, low employment rates and early labour market exits of older employees are at stake, as well as arrangements for retirement, financial household considerations and mutual obligations between generations. Although proactive behaviour has been extensively studied, no research has addressed the proactive behaviour of older employees themselves when facing (re)hiring and retention versus early retirement. For the first time, this study tests the relationships of proactive behaviour with job-related affective well-being and anticipated retirement age in a sample of employees aged 50+ (N = 89) in Belgium. The findings are obtained by using a self-report questionnaire. Statistical analysis includes correlation and regression analysis. Major findings are that (i) proactive older employees feel energetic, enthusiastic, inspired, at ease, relaxed and satisfied; and (ii) later retirement is anticipated when experiencing positive affective well-being at study.

8.
Radiology ; 257(3): 854-62, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21084417

RESUMO

PURPOSE: To compare the results obtained by using numerical flow simulations with the results of combined single photon emission computed tomography (SPECT) and computed tomography (CT) and to demonstrate the importance of correct boundary conditions for the numerical methods to account for the large amount of interpatient variability in airway geometry. MATERIALS AND METHODS: This study was approved by all relevant institutional review boards. All patients gave their signed informed consent. In this study, six patients with mild asthma (three men; three women; overall mean age, 46 years ± 17 [standard deviation]) underwent CT at functional residual capacity and total lung capacity, as well as SPECT/CT. CT data were used for segmentation and computational fluid dynamics (CFD) simulations. A comparison was made between airflow distribution, as derived with (a) SPECT/CT through tracer concentration analysis, (b) CT through lobar expansion measurement, and (c) CFD through flow computer simulation. Also, the heterogeneity of the ventilation was examined. RESULTS: Good agreement was found between SPECT/CT, CT, and CFD in terms of airflow distribution and hot spot detection. The average difference for the internal airflow distribution was less than 3% for CFD and CT versus SPECT/CT. Heterogeneity in ventilation patterns could be detected with SPECT/CT and CFD. CONCLUSION: This results of this study show that patient-specific computer simulations with appropriate boundary conditions yield information that is similar to that obtained with functional imaging tools, such as SPECT/CT. SUPPLEMENTAL MATERIAL: http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.10100322/-/DC1.


Assuntos
Asma/diagnóstico por imagem , Tomografia Computadorizada de Emissão de Fóton Único , Tomografia Computadorizada por Raios X , Adulto , Aerossóis/administração & dosagem , Idoso , Asma/fisiopatologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Modelos Anatômicos , Interpretação de Imagem Radiográfica Assistida por Computador , Compostos Radiofarmacêuticos/administração & dosagem , Testes de Função Respiratória , Software , Pentetato de Tecnécio Tc 99m/administração & dosagem
9.
Chest ; 134(6): 1169-1175, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18689597

RESUMO

BACKGROUND: To investigate the relationship between obstructive sleep apnea syndrome (OSAS) and exhaled nitric oxide (eNO) in overweight children and adolescents without asthma or atopy and to assess whether obesity per se is associated with increased airway inflammation. METHODS: Consecutive overweight subjects without symptoms of asthma or allergy were recruited at a pediatric obesity clinic. A normal-weight control group without OSAS and asthma or allergy was also recruited. All subjects underwent polysomnography and two measurements of eNO (afternoon and morning after polysomnography). RESULTS: Controlling for age, the mean (+/- SD) afternoon eNO concentration was significantly higher in the snoring group (14.1 +/- 1.1 parts per billion [ppb]) compared with the normal-weight group (10.1 +/- 0.8 ppb; p = 0.03) and with the overweight group with normal polysomnography findings (8.9 +/- 0.8 ppb; p = 0.007). The afternoon eNO concentration was also different between the OSAS group (11.9 +/- 1.0 ppb) and the overweight group with normal polysomnography findings (p = 0.03). Morning eNO values were higher in the OSAS group (12.3 +/- 1.1 ppb) than in the normal weight group (9.9 +/- 0.8 ppb; p = 0.047) and in the overweight control group (9.7 +/- 0.7 ppb; p = 0.02). BMI z score was not significantly correlated with afternoon eNO concentration or with morning eNO concentration. CONCLUSION: This study illustrates that both habitual snoring and OSAS are associated with increased airway inflammation in overweight children as assessed by higher eNO levels. Furthermore, it was demonstrated that childhood obesity in the absence of sleep-disordered breathing is not associated with increased airway inflammation.


Assuntos
Asma/epidemiologia , Obesidade/complicações , Apneia Obstrutiva do Sono/epidemiologia , Adolescente , Asma/metabolismo , Asma/fisiopatologia , Índice de Massa Corporal , Testes Respiratórios , Estudos de Casos e Controles , Criança , Estudos de Coortes , Feminino , Humanos , Masculino , Óxido Nítrico/metabolismo , Obesidade/metabolismo , Obesidade/fisiopatologia , Polissonografia , Ventilação Pulmonar/fisiologia , Fatores de Risco , Apneia Obstrutiva do Sono/metabolismo , Apneia Obstrutiva do Sono/fisiopatologia , Ronco/epidemiologia , Ronco/metabolismo , Ronco/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...